NeuroBo Pharmaceuticals Inc has a consensus price target of $6, established from looking at the 1 latest analyst ratings. The last 1 analyst ratings were released from Ladenburg Thalmann on December 7, 2022. With an average price target of $6 between Ladenburg Thalmann, there's an implied 96.72% upside for NeuroBo Pharmaceuticals Inc from these 1 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
12/07/2022 | NRBO | Buy Now | NeuroBo Pharmaceuticals | $3.05 | 96.72% | Ladenburg Thalmann | Aydin Huseynov | → $48 | Initiates | → Buy | Get Alert |
The latest price target for NeuroBo Pharmaceuticals (NASDAQ: NRBO) was reported by Ladenburg Thalmann on December 7, 2022. The analyst firm set a price target for $6.00 expecting NRBO to rise to within 12 months (a possible 96.08% upside). 0 analyst firms have reported ratings in the last year.
The latest analyst rating for NeuroBo Pharmaceuticals (NASDAQ: NRBO) was provided by Ladenburg Thalmann, and NeuroBo Pharmaceuticals initiated their buy rating.
There is no last upgrade for NeuroBo Pharmaceuticals.
There is no last downgrade for NeuroBo Pharmaceuticals.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of NeuroBo Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for NeuroBo Pharmaceuticals was filed on December 7, 2022 so you should expect the next rating to be made available sometime around December 7, 2023.
While ratings are subjective and will change, the latest NeuroBo Pharmaceuticals (NRBO) rating was a initiated with a price target of $0.00 to $6.00. The current price NeuroBo Pharmaceuticals (NRBO) is trading at is $3.06, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.